摘要
射频电磁领域的投入(含)在神经退行性疾病,特别是阿尔茨海默病(AD),已经获得了广泛的关注,然而,从一些研究结果并没有表现出一致性。在这项研究中,我们确定是否影响使用含AD的病理tg-5xfad小鼠作为阿尔茨海默病淀粉样β模型体内(-β)病理学。转基因(TG)-5XFAD和野生型(WT)小鼠长期暴露于含8个月(1950兆赫,SAR 5W/kg,2小时/天,5天/周)。值得注意的是,慢性rfemf暴露显著降低不仅β斑块、APP、APP羧基末端片段(CTF)在全脑包括海马和内嗅皮质也是β42和β40肽在tg-5xfad小鼠海马的比例。我们还发现,射频电磁场暴露在tg-5xfad抑制了β-淀粉样前体蛋白裂解酶1(BACE1)的薄壁组织的表达和神经炎症反应。此外,还能减缓tg-5xfad记忆障碍。此外,利用海马WT和TG 5XFAD以下含曝光显示5基因芯片数据的基因表达谱(tshz2、gm12695、st3gal1、ISX和TLL1),这些与Aβ有关,明显改变Tg-5xfad小鼠,在WT小鼠或tg-5xfad含野生型小鼠暴露中表现出不同的反应;类似的模式来控制tg-5xfad小鼠。然而,在TG RF-EMF暴露5XFAD小鼠表现出相反的表达模式。这些结果表明,长期暴露在含直接影响阿尔茨海默病病理Aβ但在正常的大脑。因此,含对阿尔茨海默病样Aβ高表达在晚期阿尔茨海默病小鼠的病理预防作用,这表明RF-EMF对阿尔茨海默氏病有好的影响。
关键词: 阿尔茨海默病小鼠,β-淀粉样蛋白,β-淀粉样前体蛋白裂解酶1,基因芯片,射频电磁场
Current Alzheimer Research
Title:1950 MHz Electromagnetic Fields Ameliorate Aβ Pathology in Alzheimer’s Disease Mice
Volume: 12 Issue: 5
Author(s): Ye Ji Jeong, Ga-Young Kang, Jong Hwa Kwon, Hyung-Do Choi, Jeong-Ki Pack, Nam Kim, Yun-Sil Lee and Hae-June Lee
Affiliation:
关键词: 阿尔茨海默病小鼠,β-淀粉样蛋白,β-淀粉样前体蛋白裂解酶1,基因芯片,射频电磁场
摘要: The involvement of radiofrequency electromagnetic fields (RF-EMF) in the neurodegenerative disease, especially Alzheimer’s disease (AD), has received wide consideration, however, outcomes from several researches have not shown consistency. In this study, we determined whether RF-EMF influenced AD pathology in vivo using Tg-5xFAD mice as a model of AD-like amyloid β (Aβ) pathology. The transgenic (Tg)-5xFAD and wild type (WT) mice were chronically exposed to RF-EMF for 8 months (1950 MHz, SAR 5W/kg, 2 hrs/day, 5 days/week). Notably, chronic RFEMF exposure significantly reduced not only Aβ plaques, APP, and APP carboxyl-terminal fragments (CTFs) in whole brain including hippocampus and entorhinal cortex but also the ratio of Aβ42 and Aβ40 peptide in the hippocampus of Tg-5xFAD mice. We also found that parenchymal expression of β-amyloid precursor protein cleaving enzyme 1(BACE1) and neuroinflammation were inhibited by RF-EMF exposure in Tg-5xFAD. In addition, RF-EMF was shown to rescue memory impairment in Tg-5xFAD. Moreover, gene profiling from microarray data using hippocampus of WT and Tg- 5xFAD following RF-EMF exposure revealed that 5 genes (Tshz2, Gm12695, St3gal1, Isx and Tll1), which are involved in Aβ, are significantly altered inTg-5xFAD mice, exhibiting different responses to RF-EMF in WT or Tg-5xFAD mice; RF-EMF exposure in WT mice showed similar patterns to control Tg-5xFAD mice, however, RF-EMF exposure in Tg- 5xFAD mice showed opposite expression patterns. These findings indicate that chronic RF-EMF exposure directly affects Aβ pathology in AD but not in normal brain. Therefore, RF-EMF has preventive effects against AD-like pathology in advanced AD mice with a high expression of Aβ, which suggests that RF-EMF can have a beneficial influence on AD.
Export Options
About this article
Cite this article as:
Ye Ji Jeong, Ga-Young Kang, Jong Hwa Kwon, Hyung-Do Choi, Jeong-Ki Pack, Nam Kim, Yun-Sil Lee and Hae-June Lee , 1950 MHz Electromagnetic Fields Ameliorate Aβ Pathology in Alzheimer’s Disease Mice, Current Alzheimer Research 2015; 12 (5) . https://dx.doi.org/10.2174/156720501205150526114448
DOI https://dx.doi.org/10.2174/156720501205150526114448 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
New Therapeutic Property of Dimebon as a Neuroprotective Agent
Current Medicinal Chemistry EDITOR’S PERSPECTIVE [The Challenges for Drug Development: Cytokines, Genes, and Stem Cells]
Current Neurovascular Research Neuronal Response of Peroxisomal and Peroxisome-Related Proteins to Chronic and Acute Aβ Injury
Current Alzheimer Research Mechanism of Action of Flavonoids as Anti-inflammatory Agents: A Review
Inflammation & Allergy - Drug Targets (Discontinued) Endoplasmic Reticulum Protein Quality Control in Neurodegenerative Disease: The Good, the Bad and the Therapy
Current Medicinal Chemistry Neuronal Ceroid Lipofuscinosis: The Increasing Spectrum of an Old Disease
Current Molecular Medicine Brain Drug Delivery Systems for Neurodegenerative Disorders
Current Pharmaceutical Biotechnology Humanin: A Possible Linkage Between Alzheimer’s Disease and Type 2 Diabetes
CNS & Neurological Disorders - Drug Targets Metalloproteinases and Metalloproteinase Inhibitors in Age-Related Diseases
Current Pharmaceutical Design New Cathepsin D Inhibitor Library Utilizing Hydroxyethyl Isosteres with Cyclic Tertiary Amines
Medicinal Chemistry Stem Cell-Derived Motor Neurons: Applications and Challenges in Amyotrophic Lateral Sclerosis
Current Stem Cell Research & Therapy Meet the Editorial Board Member
Current Neuropharmacology Editorial [Hot topic: Central and Peripheral Metabolic Changes in Neurodegenerative Diseases (Guest Editor: Ana Cristina Rego)]
Current Drug Targets Interplay between the APOE Genotype and Possible Plasma Biomarkers in Alzheimer’s Disease
Current Alzheimer Research Hypercortisolemia and Glucocorticoid Receptor-Signaling Insufficiency in Alzheimer’ s Disease Initiation and Development
Current Alzheimer Research Chemokines and Brain Functions
Current Drug Targets - Inflammation & Allergy Role of Prostaglandins in Multiple Sclerosis
Current Pharmaceutical Design Two Nitrogen-containing Ligands as Inhibitors of Metal-Induced Amyloid β-Peptide Aggregation
CNS & Neurological Disorders - Drug Targets Use of Fullerenes in Cosmetics
Recent Patents on Biotechnology Iron Leads to Memory Impairment that is Associated with a Decrease in Acetylcholinesterase Pathways
Current Neurovascular Research